drugset / Trial / NCT00026442

Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer

NCT00026442 ↗

Phase 2 Unknown Pharmatech Oncology
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase II trial to compare the effectiveness of two different doses of capecitabine in treating women who have advanced or metastatic breast cancer.

Timeline

Start
2001-11
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule — Oral

Indications